Organization · Venture Capital
Oxford Investment Consultants
Oxford Investment Consultants (OIC) is a venture capital firm based in Oxford, UK, specializing in early-stage investments in biotech and technology companies, particularly spinouts from leading UK research institutions.
Overview
What Oxford Investment Consultants does
What Oxford Investment Consultants is
Oxford Investment Consultants (OIC) is a venture capital firm based in Oxford, UK, specializing in early-stage investments in biotech and technology companies, particularly spinouts from leading UK research institutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find Oxford Investment Consultants elsewhere
Open the official website or a supported primary organization account.
Capability profile
Oxford Investment Consultants as a funder
Investment thesis
Oxford Investment Consultants focuses on early-stage spinouts from leading UK research universities, particularly in technology and biotech sectors, addressing significant global challenges.
Focus narrative
OIC invests in companies at various stages, from Seed through to Series C funding rounds. Their investment strategy is centered on transformative companies in biotechnology, healthcare, and technology, with a particular focus on those emerging from the 'Golden Triangle' of Oxford, Cambridge, and London.
Value beyond capital
OIC adds value to its portfolio companies through strategic guidance, leveraging its deep connections within the academic and research communities, and facilitating access to follow-on funding from top-tier investors.
Focus and fit
- Stages
- Seed · Series A · Series B · Series C
- Regions
- United KingdomEurope
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- OrganOx
Portfolio context
Notable portfolio companies include: Biofidelity: Specializes in liquid biopsy for accurate cancer diagnosis. Caristo Diagnostics: Develops software for the early diagnosis of heart disease. OrganOx: Works on extending the life of organs prior to transplant. Oxford PV: Focuses on next-generation photovoltaic technology using perovskites. SpyBiotech: A clinical-stage vaccine platform company.
Common questions
What to know about Oxford Investment Consultants
Upseed classifies Oxford Investment Consultants under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.